In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivo

Xenobiotica

Volumn 20, Issue 8, 1990, Pages 779-786

  Jajoo, H K ^a   Blair, I A ^a   Klunk, L J ^b   Mayol, R F ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; DRUG METABOLITE; METYRAPONE; PHENOBARBITAL; PROADIFEN; RADIOISOTOPE;

ANIMAL CELL; ARTICLE; DRUG METABOLISM; LIVER CELL; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BUSPIRONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; HYDROXYLATION; LIVER; MALE; MASS FRAGMENTOGRAPHY; METYRAPONE; MICROSOMES, LIVER; NADP; PHENOBARBITAL; PYRIDINES; RATS; RATS, INBRED STRAINS;

ANIMALIA;

EID: 0025179699     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259009046892     Document Type: Article

References (22)

1. The use of isolated perfused organs
2. Use of immobilized enzymes in drug metabolism studies
3. Buspirone as a mid-brain modulator: anxiolysis unrelated to the traditional benzodiazepine mechanisms
4. Buspirone: a review of its pharmacology and current perspectives on its mechanism of action
5. Serotoninergic mechanisms in the behavioral effects of buspirone and gepirone
6. Metabolism of xenobiotics in isolated cells: comparison with other in vitro systems and in vivo
7. Purified enzymes as biological models for drug metabolism
8. Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic
9. Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy
10. Metabolism of the antianxiety drug buspirone in the rat
11. Metabolism of the antianxiety drug buspirone in human subjects
12. Rat hepatocytes prepared without collagenase: prolonged retention of differentiated characteristics in culture
13. Comparison of model systems for metabolism
14. Review of the side effect profile of buspirone
15. Methods for the elevation of hepatic microsomal mixed function oxidase levels and cytochrome P-450
16. Neurophysiology of buspirone
17. Clinical studies of buspirone
18. Buspirone: a new approach to the treatment of anxiety
19. Changing concepts of the biochemical action of the anxioselective drug buspirone
20. Drug metabolizing activity of freshly isolated human hepatocytes
21. Buspirone decreases the activity of serotonin containing neurons in the dorsal raphe in free-moving cats
22. Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)-and (benzisoxathiazil-3-yl)-piperazine derivatives as potential antipsychotic agents